相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Re-purposing bridging flocculation for on-site, rapid, qualitative DNA detection in resource-poor settings
E. J. H. Wee et al.
CHEMICAL COMMUNICATIONS (2015)
Rapid DNA detection of Mycobacterium tuberculosis-towards single cell sensitivity in point-of-care diagnosis
Benjamin Y. C. Ng et al.
SCIENTIFIC REPORTS (2015)
A simple bridging flocculation assay for rapid, sensitive and stringent detection of gene specific DNA methylation
Eugene J. H. Wee et al.
SCIENTIFIC REPORTS (2015)
Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates
Riina-Minna Vaananen et al.
BMC UROLOGY (2015)
Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial
Jonathan Shoag et al.
JAMA ONCOLOGY (2015)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Prevention and early detection of prostate cancer
Jack Cuzick et al.
LANCET ONCOLOGY (2014)
A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model
Said Rahim et al.
PLOS ONE (2014)
Naked-eye detection of nucleic acids through rolling circle amplification and magnetic particle mediated aggregation
Caiqin Lin et al.
BIOSENSORS & BIOELECTRONICS (2013)
Label-free DNA quantification via a 'pipette, aggregate and blot' (PAB) approach with magnetic silica particles on filter paper
Jingyi Li et al.
LAB ON A CHIP (2013)
New Detection Modality for Label-Free Quantification of DNA in Biological Samples via Superparamagnetic Bead Aggregation
Daniel C. Leslie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
John R. Prensner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR
Chenna R. Galiveti et al.
RNA (2010)
Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gfene Expression in Castration-Resistant Prostate Cancer
Changmeng Cai et al.
CANCER RESEARCH (2009)
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
DNA detection using recombination proteins
Olaf Piepenburg et al.
PLOS BIOLOGY (2006)
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement
Maisa Yoshimoto et al.
NEOPLASIA (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Nanostructures in biodiagnostics
NL Rosi et al.
CHEMICAL REVIEWS (2005)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)